Novartis

Novartis booth at AACR 2026

Biotech

Novartis to pay $1.1B upfront for Myricx to expand ADC pipeline

Novartis is pushing deeper into ADC development, paying $1.1 billion upfront to buy Myricx Bio for a pipeline based on a novel payload.

Nick Paul Taylor Jul 6, 2026 5:10am

Goal disorientation and lack of vision

Evommune’s phase 2b flops, ending challenge to Novartis in hives

Jun 29, 2026 10:00am

Antares and Rho Ophiuchi cloud complex in the Sagittarius constellation

Novartis pays Antares $105M to tackle undruggable cancer targets

Jun 24, 2026 9:13am

NVS

Novartis dystrophy data tee up regulatory talks on Avidity drug

Jun 12, 2026 4:30am

glue scissors art supplies

Novartis sticks 2nd deal with Orionis, this one worth up to $1.4B

Jun 10, 2026 8:21am

Berlin Germany Brandenburg Gate

Fierce Pharma

Lilly, Boehringer slash investment plans in Germany

Jun 3, 2026 3:10pm